Thiopental sodium:
Thiopental is a representative intravenous anesthetic drug. There are many medications that can act as alternatives.
Injection, (powder for solution for injection), sodium thiopental, ampoules 0.5 g, and 1 g.
Uses: induction of anesthesia prior to inhalation anesthesia; short-term anesthesia.
Contraindications: inability to maintain an airway; excessive sensitivity to barbiturates, cardiovascular disease, shortness of breath or respiratory obstructive pulmonary disease;
Precautions: Local leakage can cause severe necrosis and tissue breakdown; injection into the artery causes severe pain and may result in arterial contraction; hepatic impairment; pregnancy.
Skillful work. Be warned to do skilled work, such as turning on machines, or driving, for 24 hours and avoiding alcohol abuse for 24 hours as well
Dosage:
Incubation, intravenously as a 2.5% solution (25 mg / ml) for 10-15 seconds, ADULT 100-150 mg, (reduced dose for the elderly and vulnerable) followed by 100-150 mg if necessary according to the response after 60 Second; or up to 4 mg / kg; the child 2-7 mg / kg repeated as necessary according to the response after 60 seconds.
Restructuring. Fresh solutions containing 25 mg / ml should be prepared by mixing 20 ml of injection water with the contents of the ampoule 0.5 g or 40 ml with ampoule 1 g. Any solution prepared 24 hours or in which a cloud, sediment or crystallization occurs should be excluded.
Adverse effects: Rapid injection may result in a severe reduction in blood pressure and coughs; cough, laryngeal spasm and allergic reactions.
Thiopental is a representative intravenous anesthetic drug. There are many medications that can act as alternatives.
Injection, (powder for solution for injection), sodium thiopental, ampoules 0.5 g, and 1 g.
Uses: induction of anesthesia prior to inhalation anesthesia; short-term anesthesia.
Contraindications: inability to maintain an airway; excessive sensitivity to barbiturates, cardiovascular disease, shortness of breath or respiratory obstructive pulmonary disease;
Precautions: Local leakage can cause severe necrosis and tissue breakdown; injection into the artery causes severe pain and may result in arterial contraction; hepatic impairment; pregnancy.
Skillful work. Be warned to do skilled work, such as turning on machines, or driving, for 24 hours and avoiding alcohol abuse for 24 hours as well
Dosage:
Incubation, intravenously as a 2.5% solution (25 mg / ml) for 10-15 seconds, ADULT 100-150 mg, (reduced dose for the elderly and vulnerable) followed by 100-150 mg if necessary according to the response after 60 Second; or up to 4 mg / kg; the child 2-7 mg / kg repeated as necessary according to the response after 60 seconds.
Restructuring. Fresh solutions containing 25 mg / ml should be prepared by mixing 20 ml of injection water with the contents of the ampoule 0.5 g or 40 ml with ampoule 1 g. Any solution prepared 24 hours or in which a cloud, sediment or crystallization occurs should be excluded.
Adverse effects: Rapid injection may result in a severe reduction in blood pressure and coughs; cough, laryngeal spasm and allergic reactions.
